Biotech & Health OpenAI’s Specialized Rosalind Model Poised to Revolutionize Pharma’s 15-Year Drug Pipeline OpenAI’s GPT-Rosalind could slash pharma’s brutal 15-year drug pipeline using protein reasoning and genomics. But can AI truly replace wet-lab science? AITechBrief EditorApril 17, 2026